s / Osteoarthritis and Cartilage 21 (2013) S63–S312 S130 ADAM and ADAMTS families of metalloproteinases their inhibitors the TIMPs, all CCN growth factor family members, certain FGFs and neuropeptide precursors and receptors in immortalised human chondrocytes, C28/I2. Methods: We compared the response of C28/I2 cells cultured in monolayer (2D) or on polyhema (3D; preventing cell adhesion to the culture plastic) which is known to maintain chondrocyte phenotype, exploring expression of 95 genes analysed by Taqman Low Density Array. Ten genes showed significant changes (p< 0.05) of at least 2-fold. Results: In 2D cultures Interleukin 6 (IL6) was up-regulated 3-fold by both bradykinin and Substance P. IL6 is up-regulated in OA joint fluid and elevated IL6 is associated with enhanced sensitivity to pain. Although in 3D culture no significant modulation of IL6 was observed by neuropeptides we did observe up-regulation of IL6 expression in response to IL1/Oncostatin M (used as a positive control). In 3D culture expression of six genes was significantly repressed (at least 2-fold) by both bradykinin and substance P and no genes were significantly induced. Amongst these genes it was interesting to note suppression of inhibitors TIMP2 (inhibitor of all MMPs) and TIMP3 (inhibits all MMPs, certain ADAMs and ADAMTS proteinases). Expression of three metalloproteinases, ADAMTS9 (an aggrecanase), MMP2 and MMP15 was also significantly suppressed although expression of these enzymes was still high. FGF18 was also suppressed by both neuropeptides in 3D only and this growth factor has been shown to promote cartilage repair. WISP3/ CCN6 was repressed 2-fold in 3D culture by both neuropeptides. We have previously demonstrated that WISP3/CCN6 is up-regulated in end stage OA cartilage and regulates MMP and ADAMTS4 and 5 in chondrocytes. Whilst neurotrophin BDNF expression was repressed by both neuropeptides, tachykinin 3 (the precursor to neurokinin B) was also repressed fold by bradykinin but interestingly not by the tachykinin substance P. We also explored expression of two of the genes regulated in C28/I2 cells by qPCR analysis in primary human chondrocytes and confirmed that expression of both WISP3/CCN6 and TIMP3 was also repressed by the two neuropeptides. Conclusions: Overall our data suggest that the effects of substance P and bradykinin on chondrocyte gene expression and matrix metabolism are environment-dependent. 235 LOCAL RAS IN THE HYPERTROPHIC DIFFERENTIATION OF CHONDROCYTES I. Tsukamoto y, M. Akagi y, S. Inoue y, Y. Oda y, T. Teramura z, T. Takehara z, Y. Onodera z. yDept. of Orthopaedic Surgery, Faculty of Med., Kinki Univ., Osaka-Sayama City, Japan; zDiv. of Cell Biology for Regenerative Med., Kinki Univ., Osaka-Sayama City, Japan Purpose: Recently, the local renin-angiotensin system (RAS) has attracted many researchers in many pathophysiological issues. Also in orthopedics, expression of the local RAS was found in fracture callus, bone tissues and arthritic synovium. In the last year, we reported that the local RAS expressed in chondrocytes of the epiphyseal plates of mice. The purpose of this study is to reveal immunohistological localization of the RAS components in the limb buds of mice where another physiological hypertrophic differetiation occurs and to analyze function of the local RAS in the processes of hypertrophic differentiation using ATDC5 cell line. Methods: The limb buds of 15-day-viviparous mice were immunostained with antibodies to angiotensinogen, angiotensinogen converting enzyme 1 (ACE1), angiotensinII type 1 receptor (AT1R) and angiotensinII type 2 receptor (AT2R). We cultured ATDC5 cell line and evaluated expression of angiotensinogen, ACE1, AT1R and AT2R during the hypertrophic term using quantitative real-time PCR and Western blot analysis. Then, we separately stimulated AT1R and AT2R in hypertrophic term using angiotensin II, olmesartan and PD123319 and evaluated expression of type X collagen using quantitative real-time PCR and Western blot analysis. Results: In the limb buds of mice, angiotensinogen and AT1R expressed in the resting chondrocytes, the proliferative chondrocytes and hypertrophic chondrocytes; however, ACE1 and AT2R expressed only in the hypertrophic chondrocytes. In ATDC5 cell line, angiotensinogen and AT1R expressed mainly in the proliferative term and slightly in the hypertrophic term; conversely, ACE1 and AT2R expressed mainly in the hypertrophic term and slightly in the proliferating term. In the hypertrophic term, expression of type X collagen were downregulated activating AT1R and were conversely upregulated activating AT2R. Conclusions: The local RAS also expresses in the limb buds of mice. In the hypertrophic term of the chondrocyte differentiation, activating AT1R decelerates the hypertrophic differentiation; conversely, activating AT2R accelerates the hypertrophic differentiation. Therefore, the local RAS might regulate the chondrocyte hypertrophic differentiation. 236 PRONOUNCED DECREASE IN EXPRESSION OF CHONDROPROTECTIVE SMAD2/3 PHOSPHORYLATING TGFb-SIGNALING RECEPTORS DURING AGEING IN HEALTHY CARTILAGE A. van Caam, E. Blaney Davidson, W. Madej, W. van den Berg, P. van der Kraan. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, The Netherlands Purpose: Osteoarthritis (OA) is a multi-factorial disease involving bone, synovium and cartilage, with ageing as its key risk factor. Signaling by the Transforming Growth Factor b (TGFb)-superfamily of ligands via Smad phosphorylation (SmadP) plays a crucial role in cartilage homeostasis, as Smad1/5/8p induces while Smad2/3p protects against chondrocyte hypertrophy. In cartilage, age-related changes in expression of TGFb-superfamily members, like TGFb1 and BMP7, have been observed. Furthermore, age-related changes in expression of the TGFbsuperfamily receptors ACVRL1 (ALK1) and TGFBRI (ALK5) are thought to be involved in onset of OA. Based on these findings, we wanted to investigate if gene expression of other members of the TGFb-superfamily signaling pathway changes during ageing in healthy cartilage. Therefore, in this study we set out to identify age-related changes in expression of TGFb-superfamily members and their receptors in normal cartilage. Methods: From the metacarpophalangeal joint of freshly butchered (< 3 h post mortem), cows (Bos Taurus) (n1⁄4 32, 7 male, 25 female), 28 mm2 full thickness cartilage explants were collected with a biopsy punch. Age of the animals ranged from 1 up to 10 years, and samples were evenly spread over this range. Macroscopically, none of the animals showed any signs of OA. Samples were taken from the apical side of the metacarpal chondyle medial to the intertrochlear notch, quickly washed in saline to remove synovial fluid, and flash frozen in liquid nitrogen. Cartilage was pulverized using a dismembrator and RNA was extracted using the RNAeasy method. Gene expression was measured by quantitative real time PCR, using cDNA specific primers and SYBRgreen. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as internal control. Regression analyses were done using SPSS. Results: To assess the validity of the dataset, Collagen type 2 alpha 1 (Col2A1), and Tgfb1 , expression was measured, as expression of both genes should decrease during ageing. Col2A1 expression decreased 4000-fold (R2 1⁄4 0.85, p < 0.0001) fold, and Tgfb1 over 2 fold (R2 1⁄4 0.35, p1⁄4 0.0007) in a linear fashion between young and old animals, showing that our dataset is valid for studying ageing of healthy cartilage . Subsequently expression of TGFb-superfamily type I and type II receptors was measured. Most notably, expression of all three Smad2/3 phosphorylating receptors, Acvr1b (ALK4) (R2 1⁄4 0.36, p 1⁄4 0.0043), Tgfbr1 (ALK5) (R2 1⁄4 0.21, p 1⁄4 0.0077), and Acvr1c (ALK7) (R2 1⁄4 0.26, p 1⁄4 0.0317), was lowered by, on average, 4-fold during ageing, while of the four Smad1/5/8 phosphorylating receptors only expression of Bmpr1a (ALK3) (R2 1⁄4 0.19, p 1⁄4 0.012) was lowered by 2-fold. Of the type II receptors, only a decrease of approximately 3-fold in Bmpr2 (R2 1⁄4 0.42, p 1⁄4 0.0002) expression could be observed. No change in expression of the two type III receptors Eng and Tgfbr3 was found. Furthermore no changes in expression of the following members of the Transforming Growth Factor b (TGFb)-superfamily: Tgfb2, Tgfb3, Bmp2, Bmp4, Gdf5 and Bmp7 were observed. Conclusions: Age-related changes previously observed in human and murine cartilage could also be observed in bovine cartilage, showing the validity of our dataset. We observed more changes in receptor expression than in growth factor (ligand) expression, suggesting a more important role for change in receptor expression during the ageing process compared to change in ligand expression. Strikingly, in our dataset, expression of all three Smad2/3p phosphorylating receptors was lowered during ageing, while expression of Smad1/5/8 phosphorylating receptors remained largely unaffected. Given the importance of Smad2/3p in maintaining articular cartilage phenotype, this can underlie the increased responsiveness of aged chondrocytes to processes that induce terminal differentiation.